Patents critical component to development of innovative drugs
By Mari Serebrov
Washington Editor
Washington Editor
Tuesday, January 28, 2014
If Congress wants a healthy biopharma sector that continues to produce innovative therapies to cure the world’s ills, it needs to ensure that those therapies have strong patent protection.
To continue reading subscribe now to Latest News
Learn More about Latest News
Already a subscriber? Sign In or Buy now to activate your subscription
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Reproduction, reposting content is strictly prohibited.